• Intra-Abdominal Hypertension is a Risk Factor for Increased VAP Incidence: A Prospective Cohort Study in the ICU of a Tertiary Hospital 

      Papakrivou E., Makris D., Manoulakas E., Karvouniaris M., Zakynthinos E. (2020)
      Background: Ventilator-associated pneumonia (VAP) might be increased in cases with intra-abdominal hypertension (IAH). However, despite animal experimentation and physiological studies on humans in favor of this hypothesis, ...
    • Nebulised colistin for ventilator-associated pneumonia prevention 

      Karvouniaris M., Makris D., Zygoulis P., Triantaris A., Xitsas S., Mantzarlis K., Petinaki E., Zakynthinos E. (2015)
      We evaluated whether prophylactic nebulised colistin could reduce ventilator-associated pneumonia (VAP) rates in an intensive care unit (ICU) setting with prevalent multidrug-resistant (MDR) bacteria. We used a single-centre, ...
    • Pre-intensive care unit intubation and subsequent delayed intensive care unit admission is independently associated with increased occurrence of ventilator-associated pneumonia 

      Tsakiridou E., Mega A.-M., Zakynthinos E., Melissopoulou T., Stamos G., Argyriou K., Pangrati S., Deliolanis I., Floros I. (2018)
      Introduction: Critically ill intubated patients are at risk for ventilator-associated pneumonia. However, intubation may not occur in intensive care unit (ICU) and subsequent ICU admission may be delayed. Objectives: To ...
    • Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study 

      Saura O., Rouzé A., Martin-Loeches I., Povoa P., Kreitmann L., Torres A., Metzelard M., Du Cheyron D., Lambiotte F., Tamion F., Labruyere M., Boulle Geronimi C., Luyt C.-E., Nyunga M., Pouly O., Thille A.W., Megarbane B., Saade A., Magira E., Llitjos J.-F., Ioannidou I., Pierre A., Reignier J., Garot D., Baudel J.-L., Voiriot G., Plantefeve G., Morawiec E., Asfar P., Boyer A., Mekontso-Dessap A., Bardaka F., Diaz E., Vinsonneau C., Floch P.-E., Weiss N., Ceccato A., Artigas A., Nora D., Duhamel A., Labreuche J., Nseir S., Bouchereau M., Boyd S., Coelho L., Maizel J., Cuchet P., Zarrougui W., Boyer D., Quenot J.-P., Imouloudene M., Pineton de Chambrun M., Van der Linden T., Arrive F., Voicu S., Azoulay E., Moglia E., Pene F., Cilloniz C., Thevenin D., Larrat C., Argaud L., Guidet B., Contou D., Beurton A., Meguerditchian D., Razazi K., Tsolaki V., Marzouk M., Brunin G., Marois C., Morales L., coVAPid Study Group (2022)
      Background: Ventilator-associated pneumonia (VAP) is common in patients with severe SARS-CoV-2 pneumonia. The aim of this ancillary analysis of the coVAPid multicenter observational retrospective study is to assess the ...
    • Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study 

      Rouzé A., Martin-Loeches I., Povoa P., Makris D., Artigas A., Bouchereau M., Lambiotte F., Metzelard M., Cuchet P., Boulle Geronimi C., Labruyere M., Tamion F., Nyunga M., Luyt C.-E., Labreuche J., Pouly O., Bardin J., Saade A., Asfar P., Baudel J.-L., Beurton A., Garot D., Ioannidou I., Kreitmann L., Llitjos J.-F., Magira E., Mégarbane B., Meguerditchian D., Moglia E., Mekontso-Dessap A., Reignier J., Turpin M., Pierre A., Plantefeve G., Vinsonneau C., Floch P.-E., Weiss N., Ceccato A., Torres A., Duhamel A., Nseir S., Favory R., Preau S., Jourdain M., Poissy J., Bouras C., Saint Leger P., Fodil H., Aptel F., Van Der Linden T., Thille A.W., Azoulay E., Pène F., Razazi K., Bagate F., Contou D., Voiriot G., Thevenin D., Guidet B., Le Guennec L., Kouatchet A., Ehrmann S., Brunin G., Morawiec E., Boyer A., Argaud L., Voicu S., Nieszkowska A., Kowalski B., Goma G., Diaz E., Morales L., Tsolaki V., Gtavriilidis G., Mentzelopoulos S.D., Nora D., Boyd S., Coelho L., Maizel J., Du Cheyron D., Imouloudene M., Quenot J.-P., Guilbert A., Cilloniz C., on behalf of the coVAPid study Group (2021)
      Purpose: Although patients with SARS-CoV-2 infection have several risk factors for ventilator-associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital-acquired infections is low. We aimed ...
    • Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort 

      Nseir S., Martin-Loeches I., Povoa P., Metzelard M., Du Cheyron D., Lambiotte F., Tamion F., Labruyere M., Makris D., Boulle Geronimi C., Pinetonde Chambrun M., Nyunga M., Pouly O., Mégarbane B., Saade A., Gomà G., Magira E., Llitjos J.-F., Torres A., Ioannidou I., Pierre A., Coelho L., Reignier J., Garot D., Kreitmann L., Baudel J.-L., Voiriot G., Contou D., Beurton A., Asfar P., Boyer A., Thille A.W., Mekontso-Dessap A., Tsolaki V., Vinsonneau C., Floch P.-E., Le Guennec L., Ceccato A., Artigas A., Bouchereau M., Labreuche J., Duhamel A., Rouzé A., Favory R., Préau S., Jourdain M., Poissy J., Leger P.S., Van der Linden T., Veinstein A., Azoulay E., Pene F., Martin M., Razazi K., Plantefeve G., Fartoukh M., Thevenin D., Guidet B., Weiss N., Kouatchet A., Salmon C., Brunin G., Nemlaghi S., Meguerditchian D., Argaud L., Voicu S., Luyt C.-E., Kowalski B., Moglia E., Morales L., Koutsoukou A., Mentzelopoulos S.D., Nora D., Boyd S., Maizel J., Cuchet P., Delforge Q., Quenot J.-P., Boyer D., Cilloniz C., the coVAPid study group (2021)
      Background: Patients with SARS-CoV-2 infection are at higher risk for ventilator-associated pneumonia (VAP). No study has evaluated the relationship between VAP and mortality in this population, or compared this relationship ...
    • Ten ineffective interventions to prevent ventilator-associated pneumonia 

      Makris D., Luna C., Nseir S. (2018)
      [No abstract available]
    • Wet chemical silver treatment of endotracheal tubes to produce antibacterial surfaces 

      Ramstedt, M.; Houriet, R.; Mossialos, D.; Haas, D.; Mathieu, H. J. (2007)
      Mechanically ventilated patients in hospitals are subjected to an increased risk of acquiring nosocomial pneumonia that sometimes has a lethal outcome. One way to minimize the risk could be to make the surfaces on endotracheal ...